[go: up one dir, main page]

ATE124258T1 - Schilddrüsenhormone zur kardialen behandlung. - Google Patents

Schilddrüsenhormone zur kardialen behandlung.

Info

Publication number
ATE124258T1
ATE124258T1 AT91904573T AT91904573T ATE124258T1 AT E124258 T1 ATE124258 T1 AT E124258T1 AT 91904573 T AT91904573 T AT 91904573T AT 91904573 T AT91904573 T AT 91904573T AT E124258 T1 ATE124258 T1 AT E124258T1
Authority
AT
Austria
Prior art keywords
cardial
treatment
thyroid hormones
thyroid
hormones
Prior art date
Application number
AT91904573T
Other languages
English (en)
Inventor
Leo Rubin
Original Assignee
British Tech Group Usa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group Usa filed Critical British Tech Group Usa
Application granted granted Critical
Publication of ATE124258T1 publication Critical patent/ATE124258T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
AT91904573T 1990-02-05 1991-02-05 Schilddrüsenhormone zur kardialen behandlung. ATE124258T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47536090A 1990-02-05 1990-02-05
US49535490A 1990-03-19 1990-03-19

Publications (1)

Publication Number Publication Date
ATE124258T1 true ATE124258T1 (de) 1995-07-15

Family

ID=27044760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91904573T ATE124258T1 (de) 1990-02-05 1991-02-05 Schilddrüsenhormone zur kardialen behandlung.

Country Status (7)

Country Link
EP (1) EP0466909B1 (de)
JP (1) JP3084059B2 (de)
AT (1) ATE124258T1 (de)
CA (1) CA2051369C (de)
DE (1) DE69110779T2 (de)
GB (1) GB2240474B (de)
WO (1) WO1991011181A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571840A (en) * 1993-06-22 1996-11-05 The Regents Of The University Of Michigan Method for treating central nervous system ischemia
SE501834C2 (sv) * 1993-09-22 1995-05-22 Moelnlycke Ab Superabsorberande fiber eller fibertyg, förfarande för dess framställning samt absorberande alster innefattande den
WO2002051403A1 (en) * 2000-12-21 2002-07-04 Resuscitek, Inc. Compositions of stable t3 and methods of use thereof
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
US7829552B2 (en) 2003-11-19 2010-11-09 Metabasis Therapeutics, Inc. Phosphorus-containing thyromimetics
SI1811987T1 (sl) * 2004-11-18 2008-08-31 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Suh prah, ki obsega levotiroksin natrij, ki ga dajemo preko inhalatorja
JP2008542301A (ja) 2005-05-26 2008-11-27 メタバシス・セラピューティクス・インコーポレイテッド 脂肪性肝疾患の処置のための甲状腺ホルモン様薬剤
US20120190748A1 (en) * 2009-08-04 2012-07-26 Haren Treasurer Greater utility with thyroid hormone
BR112019010249A2 (pt) 2016-11-21 2019-09-10 Viking Therapeutics Inc método de tratamento de doença de armazenamento de glicogênio
AU2018280118B2 (en) 2017-06-05 2021-07-15 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis
AU2019238090B2 (en) 2018-03-22 2024-08-01 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
US12102646B2 (en) 2018-12-05 2024-10-01 Viking Therapeutics, Inc. Compositions for the treatment of fibrosis and inflammation
LT3908272T (lt) * 2019-01-09 2023-06-12 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. L-trijodtironinas (t3), skirtas panaudoti apribojant mikrokraujagyslių obstrukciją

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH622703A5 (en) * 1976-06-10 1981-04-30 Berema Sa Therapeutic compositions for treating deposits of excess fat and infiltrates causing cellulite
JPH07116031B2 (ja) * 1986-09-24 1995-12-13 株式会社アドバンス 制癌剤
SE461013B (sv) * 1988-02-11 1989-12-18 Christian Wesslau Farmaceutisk komposition verksam mot lungobstruktioner bestaaende av en betaadrenerg antagonist och ett tyroideahormon

Also Published As

Publication number Publication date
EP0466909B1 (de) 1995-06-28
GB9102430D0 (en) 1991-03-20
WO1991011181A1 (en) 1991-08-08
GB2240474A (en) 1991-08-07
JPH04506667A (ja) 1992-11-19
DE69110779T2 (de) 1995-12-07
EP0466909A1 (de) 1992-01-22
DE69110779D1 (de) 1995-08-03
CA2051369C (en) 2002-01-01
CA2051369A1 (en) 1991-08-06
JP3084059B2 (ja) 2000-09-04
GB2240474B (en) 1994-01-12

Similar Documents

Publication Publication Date Title
NL194748B (nl) Osmotische doseringsvorm voor behandeling van cardiovasculaire ziekten.
DE3855489D1 (de) Behandlung von Hautfalten
DE122005000002I1 (de) Verwendung von Venlafaxin oder eines Aryloxy-Propanaminderivates zur Herstellung eines Medikaments zur Behandlung von Inkontinenz.
ATE124258T1 (de) Schilddrüsenhormone zur kardialen behandlung.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE69019488D1 (de) Behandlung von Geflügel.
DE69018043D1 (de) Behandlung von Geflügel.
DK617687A (da) Bestraalingsanordning til medicinsk behandling
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE3687692D1 (de) Geschlechtshormone zur behandlung von immun-mangel-krankheiten.
DK360687A (da) Bestraalingsanordning til medicinsk behandling
ATE11013T1 (de) Heilmittelzusammensetzungen zur behandlung der haut.
FI902653A0 (fi) Valmiste hampaiden hoitamiseksi sekä valmisteen valmistus
DK152587A (da) Bestraalingsanordning til medicinsk behandling
NO880292D0 (no) Fremgangsmaate for behandling av humle.
DK24887D0 (da) Bestraalingsanordning til medicinsk behandling
DK24987D0 (da) Bestraalingsanordning til medicinsk behandling
DK650087D0 (da) Bestraalingsanordning til medicinsk behandling
DK24587D0 (da) Bestraalingsanordning til medicinsk behandling
JPS5547857A (en) Appliance for medical treatment
IT1164507B (it) Apparecchio di trattamento dentistico
DE3280419D1 (de) Medizinisches praeparat zur behandlung von hautleiden.
NO884635D0 (no) Fremgangsmaate for behandling av most.
JPS54128195A (en) Appliance for medical treatment
FI831258L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara benzimidazolderivat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties